From artificial intelligence to analytics advances, fintech is changing the wealth management industry. Pexels

Today's technologies have changed the wealth management industry by providing innovative tools to help empower clients and may allow a more productive and beneficial working relationship between financial advisers and their clients. Whether someone is saving for retirement, college, a new business, or travel, I have found that with new technologies, I am better able to communicate with my clients and help them meet their holistic investment goals.

It is an exciting time for wealth management. The industry is on the cutting edge of creating and adopting new technologies and innovations to empower financial advisers to engage and manage our clients' assets. Technologies such as artificial intelligence and risk analytics can provide financial advisers with a more complete picture of their clients' financial lives, which in turn helps us monitor progress and adjust course as needed.

Clients want a trusted adviser to guide them in meeting their financial goals, and now I am able to implement new technologies that help me provide a higher level of service. Using new platforms, I am able to provide real-time information and advice to my clients. I can use this technology to tailor information to their specific investments, how the market is affecting them, and determine what moves to recommend to help them get them closer to their financial goals.

With recent volatility in the market, having immediate, real-time information helps me to change direction within a client's portfolio if needed, and has been a true blessing. The risk analytics platform enables me to identify financial risks that my clients may be exposed to and allows us to quickly change course if necessary. It's a powerful way to engage. Communicating expeditiously and efficiently is important with all clients including those that have large, diversified portfolios.

Lastly, as some clients mature in age, I have begun working with them and their adult children. Together, we use technology applications to monitor the portfolio's progress to meeting the client's goals. The technological tools available within the wealth management industry have become a beneficial way to conduct business with these younger generations, especially Millennials.

As the world continues to incorporate additional technologies into all facets of life, the new tools available to wealth managers can be impactful. We can improve our relationships with clients, provide dependable information, and help guide their decisions so they may achieve their goals in life.

------

Margo Geddie is senior vice president and financial adviser with the wealth management division of Morgan Stanley in Houston.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”